Clinical Trial Highlights: Targetting Alpha-Synuclein

J Parkinsons Dis. 2019;9(1):5-16. doi: 10.3233/JPD-189004.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Clinical Trial Protocols as Topic*
  • Clinical Trials as Topic*
  • Humans
  • Immunotherapy*
  • Middle Aged
  • Parkinson Disease / therapy*
  • Young Adult
  • alpha-Synuclein* / drug effects
  • alpha-Synuclein* / immunology

Substances

  • SNCA protein, human
  • alpha-Synuclein

Associated data

  • ClinicalTrials.gov/NCT01568099
  • ClinicalTrials.gov/NCT01885494
  • ClinicalTrials.gov/NCT02216188
  • ClinicalTrials.gov/NCT02618941